James Li

2.1k total citations
39 papers, 700 citations indexed

About

James Li is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, James Li has authored 39 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Genetics. Recurrent topics in James Li's work include CAR-T cell therapy research (8 papers), BRCA gene mutations in cancer (4 papers) and Genetic Associations and Epidemiology (4 papers). James Li is often cited by papers focused on CAR-T cell therapy research (8 papers), BRCA gene mutations in cancer (4 papers) and Genetic Associations and Epidemiology (4 papers). James Li collaborates with scholars based in United States, China and France. James Li's co-authors include Michael C. Holmes, Philip D. Gregory, Maria Jasin, Peter J. McKinnon, Edward J. Rebar, Deniz Simsek, Lei Zhang, Yankun Gao, Sunnie Wong and Sachin Katyal and has published in prestigious journals such as Nucleic Acids Research, Blood and Development.

In The Last Decade

James Li

35 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Li United States 10 474 217 135 70 56 39 700
Yanjiao Shao China 15 618 1.3× 75 0.3× 248 1.8× 32 0.5× 25 0.4× 25 847
Yuqi Tan United States 15 539 1.1× 79 0.4× 30 0.2× 93 1.3× 77 1.4× 33 819
Kamila Gwiazda United States 7 456 1.0× 113 0.5× 208 1.5× 37 0.5× 47 0.8× 10 727
Shuo Huang China 11 304 0.6× 42 0.2× 66 0.5× 14 0.2× 45 0.8× 27 540
Julia O’Sullivan Canada 8 268 0.6× 195 0.9× 41 0.3× 27 0.4× 57 1.0× 14 474
Daniel Lai Canada 13 632 1.3× 55 0.3× 119 0.9× 19 0.3× 30 0.5× 21 877
Michael Sterr Germany 17 703 1.5× 104 0.5× 259 1.9× 65 0.9× 79 1.4× 33 1.1k
Ling Ge China 15 241 0.5× 33 0.2× 80 0.6× 28 0.4× 32 0.6× 33 506
Xiaonan Fu United States 14 395 0.8× 135 0.6× 49 0.4× 31 0.4× 66 1.2× 19 670

Countries citing papers authored by James Li

Since Specialization
Citations

This map shows the geographic impact of James Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Li more than expected).

Fields of papers citing papers by James Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Li. The network helps show where James Li may publish in the future.

Co-authorship network of co-authors of James Li

This figure shows the co-authorship network connecting the top 25 collaborators of James Li. A scholar is included among the top collaborators of James Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Li. James Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richardson, M. I., Curtis R. Brandt, James Li, et al.. (2025). Characterization of DNA methylation clock algorithms applied to diverse tissue types. Aging. 17(1). 67–96. 2 indexed citations
2.
Li, James, et al.. (2024). Declination of Treatment, Racial and Ethnic Disparity, and Overall Survival in US Patients With Breast Cancer. JAMA Network Open. 7(5). e249449–e249449. 8 indexed citations
3.
Li, James, Tong Lin, Farzana Jasmine, et al.. (2024). The association of cigarette smoking with DNA methylation and gene expression in human tissue samples. The American Journal of Human Genetics. 111(4). 636–653. 11 indexed citations
5.
Li, James, Tong Lin, Farzana Jasmine, et al.. (2024). DNA methylation correlates of chronological age in diverse human tissue types. Epigenetics & Chromatin. 17(1). 25–25. 3 indexed citations
6.
Barbeira, Alvaro, et al.. (2024). A multi-tissue, splicing-based joint transcriptome-wide association study identifies susceptibility genes for breast cancer. The American Journal of Human Genetics. 111(6). 1100–1113. 4 indexed citations
8.
Gao, Guimin, et al.. (2023). A joint transcriptome-wide association study across multiple tissues identifies candidate breast cancer susceptibility genes. The American Journal of Human Genetics. 110(6). 950–962. 12 indexed citations
9.
Li, James, Sarah R. Greytak, Ping Guan, et al.. (2022). Formalin Fixation, Delay to Fixation, and Time in Fixative Adversely Impact Copy Number Variation Analysis by aCGH. Biopreservation and Biobanking. 21(4). 407–416. 2 indexed citations
11.
Li, James, David Gordon, Harkness Kuck, et al.. (2021). Synonymous variants that disrupt messenger RNA structure are significantly constrained in the human population. GigaScience. 10(4). 13 indexed citations
12.
Sun, Weimin, Ke Zhang, Yan Liu, et al.. (2020). Development and Validation of a 34‐Gene Inherited Cancer Predisposition Panel Using Next‐Generation Sequencing. BioMed Research International. 2020(1). 3289023–3289023. 5 indexed citations
13.
Li, Li, Wen Wang, Shu Cheng, et al.. (2019). Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma. Clinical Cancer Research. 25(23). 6995–7003. 88 indexed citations
14.
Ying, Zhitao, Pengpeng Xu, Li Wang, et al.. (2019). Clinical Response in Relapsed/Refractory (R/R) B-NHL Treated with the CD19-Directed CAR T-Cell Product JWCAR029. Blood. 134(Supplement_1). 2876–2876. 7 indexed citations
15.
Thase, Michael E., Sagar V. Parikh, Anthony J. Rothschild, et al.. (2019). Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial. The Journal of Clinical Psychiatry. 80(6). 47 indexed citations
16.
Yan, Zi‐Xun, Wen Wang, Zhong Zheng, et al.. (2018). Efficacy and Safety of JWCAR029 in Adult Patients with Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma. Blood. 132(Supplement 1). 4187–4187. 6 indexed citations
17.
Yuan, Hongyan, Xiaoyi Wang, Chunmei Shi, et al.. (2018). Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis. Scientific Reports. 8(1). 5717–5717. 13 indexed citations
18.
Simsek, Deniz, Erika Brunet, Sunnie Wong, et al.. (2011). DNA Ligase III Promotes Alternative Nonhomologous End-Joining during Chromosomal Translocation Formation. PLoS Genetics. 7(6). e1002080–e1002080. 237 indexed citations
19.
Orlando, Salvatore J., Yolanda Santiago, Russell C. DeKelver, et al.. (2010). Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology. Nucleic Acids Research. 38(15). e152–e152. 147 indexed citations
20.
Li, James, et al.. (2002). Curriculum in Physician—Patient Communication Skills for New Faculty. Academic Medicine. 77(5). 462–462. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026